Showing results (41-50 of 142) with videos related to
Sort By:
Pageof 15
Cancer Research|September 17, 2005
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effectsTania Maffucci, Enza Piccolo, Albana Cumashi, et al.Frontiers in Endocrinology|October 27, 2018
Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1Silvano Paternoster, Marco FalascaWorld Journal of Gastroenterology|August 26, 2014
Emerging role of the KRAS-PDK1 axis in pancreatic cancerRiccardo Ferro, Marco FalascaBiomolecules|February 25, 2022
Targeting the Endocannabinoidome in Pancreatic CancerValerio Falasca, Marco FalascaOncotarget|March 3, 2016
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progressionAnissa Chikh, Riccardo Ferro, Jonathan J Abbott, et al.Cancers|July 29, 2020
Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to ChemotherapyAikaterini Emmanouilidi, Ilaria Casari, Begum Gokcen Akkaya, et al.International Journal of Molecular Sciences|November 9, 2017
ABC Transporters in Cancer Stem Cells: Beyond ChemoresistanceRomana-Rea Begicevic, Marco FalascaExpert Opinion on Investigational Drugs|April 13, 2012
Investigational ABC transporter inhibitorsMarco Falasca, Kenneth J LintonMetabolites|January 20, 2016
Lysophosphatidylinositol Signalling and Metabolic DiseasesSyamsul A Arifin, Marco FalascaPageof 15